Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CareRxTSX:CRRX +0.60%66 Days Payable is 49.59 as of Jun. 2026, which is 8% above its 10-year median of 46.00. GuruFocus rates TSX:CRRX with a GF Score™ of 66/100 and a GF Value™ of C$2.28 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 607 Healthcare Providers & Services companies, CareRx ranks worse than 59.97% on this metric.
CareRx's average Accounts Payable for the
three
months ended in Jun. 2026 was C$35.9 Mil. CareRx's Cost of Goods Sold for the
three
months ended in Jun. 2026 was C$66.0 Mil.
Hence, CareRx's Days Payable for the
three
months ended in Jun. 2026 was 49.59.
The historical rank and industry rank for CareRx's Days Payable or its related term are showing as below:
TSX:CRRX'
s Days Payable Range Over the Past 10 Years
Min: 40.88 Med: 46 Max: 65.48
Current: 45.71
During the past 13 years, CareRx's highest Days Payable was 65.48. The lowest was 40.88. And the median was 46.00.
TSX:CRRX's Days Payable is ranked worse than 59.97% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 56.95
vs TSX:CRRX: 45.71
CareRx's Days Payable
increased
from Jun. 2025 (42.30) to Jun. 2026 (49.59).
It may suggest that CareRxdelayed paying its suppliers.
The historical data trend for CareRx's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSX:CRRX vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, CareRx's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CareRx Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CareRx's Days Payable distribution charts can be found below:
* The bar in red indicates where CareRx's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CareRx's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CareRx (TSX:CRRX) has a Days Payable of 49.59 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CareRx and its competitors. This is near median its historical median of 46.00. Over the past decade, CareRx's Days Payable has ranged from 40.88 to 65.48. According to the industry distribution chart, CareRx ranks #364 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 60%.
Is CareRx's Days Payable too high?
CareRx's current Days Payable of 49.59 is near median its 10-year median of 46.00. Over the past 10 years, this metric has ranged from a low of 40.88 to a high of 65.48. The Healthcare Providers & Services industry median Days Payable is 56.95. CareRx's value of 49.59 is 12.9% below this industry median. Based on the distribution chart, CareRx ranks #364 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, CareRx has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CareRx's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CareRx ranks #364 out of 607 companies for Days Payable. This places CareRx in the lower half of its industry. The industry median Days Payable is 56.95. CareRx's value of 49.59 is 12.9% below this benchmark. Historically, CareRx's own Days Payable has ranged from 40.88 to 65.48 over the past decade. While the company's 10-year median is 46.00 vs. the industry median of 56.95, CareRx has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.95, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CareRx's current Days Payable of 49.59 is 12.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CareRx and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CareRx's current Days Payable is 49.59, which is near median its own 10-year median of 46.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CareRx stock overvalued right now?
Based on GuruFocus' analysis, CareRx (TSX:CRRX) is currently considered Significantly Overvalued. The stock's GF Value™ is C$2.28, compared to a current price of C$3.37 — trading 47.8% above its estimated fair value. The current Days Payable is 49.59, which is near median its 10-year median of 46.00 and 12.9% below the Healthcare Providers & Services industry median of 56.95. CareRx's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CareRx (TSX:CRRX), the current Days Payable is 49.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CareRx (TSX:CRRX) Overvalued in 2026?
Based on GuruFocus' analysis, CareRx stock appears to be overvalued.
The current stock price of C$3.37 is trading 47.8% above its estimated GF Value™ of C$2.28.
GuruFocus considers CareRx to be Significantly Overvalued.
Key valuation signals for TSX:CRRX:
Days Payable: 49.59 (near median its 10-year median of 46.00)
GF Value™: C$2.28 vs. price of C$3.37 (47.8% above fair value)
Industry Position: 12.9% below the Healthcare Providers & Services median (#364 of 607)
No single metric tells the full story. See the TSX:CRRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education and medication system quality and efficiency. The Company has one reportable segment which consists of the Company-owned and operated institutional pharmacy business. Geographically it derives revenue from the sales of goods and capitated service fees in Ontario and Western Canada.
66GF Score
Get the complete analysis for TSX:CRRX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:CRRX has been successfully added to your 
